International Flavors & Fragrances Inc (IFF)

NYSE
Currency in USD
84.89
+0.45(+0.53%)
Closed
Pre Market
84.38-0.51(-0.60%)
IFF Scorecard
Full Analysis
High shareholder yield
Earnings results expected in 15 days
Fair Value
Day's Range
84.1385.36
52 wk Range
72.94106.77
Key Statistics
Edit
Prev. Close
84.89
Open
84.81
Day's Range
84.13-85.36
52 wk Range
72.94-106.77
Volume
1.12M
Average Volume (3m)
1.47M
1-Year Change
6.75%
Book Value / Share
57.79
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IFF Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
105.29
Upside
+24.03%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

IFF Company Profile

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in the United States, Europe, and internationally. It operates through four segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds used in savory products; beverages; sweets; and dairy products. It also provides value-added spices and seasoning ingredients; savory solutions, including spices, sauces, marinades, and mixtures; and natural antioxidants and anti-microbials. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients for food and non-food applications. Its Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that include natural flavor extracts, specialty botanical extracts, distillates, essential oils, citrus products, aroma chemicals, natural gums, and resins; and cosmetic active ingredients consisting of active and functional ingredients, and delivery systems for cosmetic and personal care product industries. Its Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.

Employees
21500

International Flavors & Fragrances Inc SWOT Analysis


Financial Resilience
IFF's strong Q3 2024 results and projected EPS growth for FY2025 showcase the company's ability to maintain market position amid economic challenges
Market Dynamics
Explore IFF's position in the evolving flavors and fragrances industry, balancing a $22.39B market cap with anticipated growth normalization in 2025
Industry Adaptation
Delve into sector-wide transitions, including cautious optimism in customer orders and the impact of higher yields on investment environments
Strategic Outlook
Analysts maintain an optimistic stance with an average price target of $94, despite concerns over weaker volume trends in end-markets
Read full SWOT analysis

International Flavors & Fragrances Inc Earnings Call Summary for Q3/2024

  • IFF raises full-year guidance: Net sales $11.3-11.4B, adjusted EBITDA at high end of $2.1-2.17B range
  • Q3 revenue surpassed $2.9B, up 9% on comparable currency-neutral basis; high-single-digit volume growth across units
  • Pharma Solutions divestiture planned for H1 2025; organizational changes for Flavors and Functional Ingredients separation in 2024
  • Cautious Q4 outlook due to potential customer inventory adjustments; free cash flow guidance remains at ~$600M
  • Focus on innovation and productivity for 2025; strong growth in Nourish, Health & Biosciences, and Pharma Solutions segments
Last Updated: 07/11/2024, 07:52
Read Full Transcript

Compare IFF to Peers and Sector

Metrics to compare
IFF
Peers
Sector
Relationship
P/E Ratio
−9.4x28.3x−0.1x
PEG Ratio
0.000.070.00
Price/Book
1.5x1.8x1.6x
Price / LTM Sales
1.9x1.0x1.2x
Upside (Analyst Target)
24.9%13.3%30.2%
Fair Value Upside
Unlock10.6%2.6%Unlock

Analyst Ratings

16 Buy
5 Hold
1 Sell
Ratings:
22 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 105.29
(+24.03% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -9.1
Dividend Yield
1.88%
Industry Median 3.35%
Annualised payout
1.6000
Paid quarterly
5-Years Growth
-7.32%
Growth Streak

Earnings

Latest Release
Nov 05, 2024
EPS / Forecast
1.04 / 1.07
Revenue / Forecast
2.93B / 2.83B
EPS Revisions
Last 90 days

People Also Watch

38.98
CPB
-0.71%
262.87
EFX
-0.52%
197.36
IQV
-0.15%
515.70
IT
+0.71%

FAQ

What Is the IFF (IFF) Stock Price Today?

The IFF stock price today is 84.89

What Stock Exchange Does IFF Trade On?

IFF is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for IFF?

The stock symbol for IFF is "IFF."

Does IFF Pay Dividends? What’s The Current Dividend Yield?

The IFF dividend yield is 1.88%.

What Is the IFF Market Cap?

As of today, IFF market cap is 21.70B.

What is IFF Earnings Per Share?

The IFF EPS is -9.10.

What Is the Next IFF Earnings Date?

IFF will release its next earnings report on 05 Feb 2025.

From a Technical Analysis Perspective, Is IFF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.